Y. (1996). Structure and function of the yeast vacuolar membrane h

(1)

BIBLIOGRAFIA

• A

NRAKU

Y. (1996). Structure and function of the yeast vacuolar membrane h

⁺

ATPase. Handbook of Biological Physics, vol. 2 (ed.

W.N. Konings, H.R. Kaback and J.S. Lolkema), Elsevier Science, Amsterdam: 99-109.

• A

^RATA

Y., N

ISHI

T., K

AWASAKI

-N

ISHI

S., S

HAO E

., W

ILKENS

S., F

ORGAC

M. (2002). Structure, subunit function and regulation of the coated vesicle and yeast vacuolar (H

⁺

)-ATPases. Biochim. Biophys.

Acta. 1555: 71-74.

• A

^RDUINI

A., D

ENISOVA

N., V

IRMANI

MA., A

VROVA

N., F

EDERICI

G., A

RRIGONI

-M

ARTELLI

E.(1994). Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triacylglycerol and phospholipid fatty acid turnover. J. Neurochem. 62:

1530-1538.

• A

TTARDI

G.

AND

S

CHATZ

G.(1988). Biogenesis of mitochondrial. Annu.

Rev. Cell. Biol. 4: 289-333.

• B

AHL

JJ., B

RESSLER

R. (1987). The pharmacology of carnitine. Annu.

Rev. Pharmacol. Toxicol. 27: 257-277.

• B

ERTAMINI

M., M

ARZANI

B., G

UARNERI

P., B

IGINI

P., M

ENNINI

T., C

URTI

D. (2002). Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur. J. Neurosci.

16: 2291-2296.

• B

ERTONI

-F

REDDARI

C., F

ATTORETTI

P., C

ASOLI

T., S

PAGNA

C.

AND

C

ASELL

U. (1994). Dynamic morphology of the synaptic junctional areas during aging: the effect of chronic acetyl-L-carnitine administration. Brain Res. 656: 359-366.

• B

^ILLUPS

B.

AND

F

ORSYTHE

ID. (2002). Presynaptic mitochondrial calcium sequestration influences trasmission at mammalian central synapses. J. Neursci. 22: 5840-5847.

• B

^LALOCK

JE. (1994). The syntax of immune-neuroendocrine

communication. Immunol. Today. 15: 504-511.

(2)

• B

LOKLAND

A., B

OTHERM

J., H

ONIG

W., J

OLLES

J. (1993). Behavioural and biochemical effects of acute central metabolic inhibition: effect of acetyl-l-carnitine. Eur. J. Pharmacol. 235: 275-281.

• B

ONAVITA

E. (1986). Study of the efficacy and tolerability of L- acetylcarnitine therapy in the senile brain. Int. J. Clin. Pharmacol.

Ther. Toxicol. 24: 511-516.

• B

RESOLIN

N., F

REDDO

L., V

ERGANI

L., A

NGELINI

C. (1982).

Carnitine, carnitine acyltransferases, and rat brain function.

Exp. Neurol. 78: 285-292.

• B

RUSTOVETSKY

N.

AND

D

UBINSKY

JM. (2000). Limitations of cyclosporin A inhibition of the permeability transition in CNS mitochondria. J. Neurosci. 20: 8229-8237.

• C

^AIRO

G., B

ARDELLA

L., S

CHIAFFONATI

L., A

ROSIO

P., L

EVI

S., B

ERNELLI

-Z

AZZERA

A. (1985). Multiple mechanisms of iron-induced ferritin synthesis in HeLa cells. Biochem. Biophhys. Res. Comm. 133:

314-321.

• C

^ALVANI

M., C

ARTA

A., C

ARUSO

G., B

ENEDETTI

N.

AND

I

ANNUCCELLI

M. (1992). Action of acetyl-L-carnitine in neurodegeneration and Alzheimer's disease. Ann. N. Y. Acad. Sci. 663: 483-486.

• C

^ASTORINA

M., A

MBROSINI

AM., G

IULIANI

A., P

ACIFICI

L., R

AMACCI

MT.

AND

A

NGELUCCI

L. (1993). A cluster analysis of L-carnitine effect on NMDA receptors in aging. Exp. Gerontol. 28: 537-548.

• C

^ASTORINA

M., A

MBROSINI

AM., P

ACIFICI

L., R

AMACCI

MT.

AND

A

NGELUCCI

L. (1994). Age-dependent loss of NMDA receptors in hippocampus, striatum, and frontal cortex of the rat: prevention by acetyl-L-carnitine. Neurochem. Res. 19: 795-798.

• C

HEEPSUNTHORN

P., P

ALMER

C., M

ENZIES

S., R

OBERTS

RL., C

ONNOR

JR. (2001). Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains. J. Comp. Neurol. 431: 382-396.

• C

HIECHIO

S., C

ARICASOLE

A., B

ARLETTA

E., S

TORTO

M., C

ATANIA

M.V., C

OPANI

A., V

ERTHECHY

M., N

ICOLAI

R., C

ALVANI

M.,

M

ELCHIORRI

D., N

ICOLETTI

F. (2002). L-Acetylcarnitine induces

(3)

analgesia by selectively up-regulation mGLU2 metabotropic glutamate receptors. Mol Pharmacol. 61: 989-996.

• C

OLOMBINI

M., B

LACHLY

-D

YSON

E., F

ORTE

M. (1996). VDCA, a channel in the outer mitochondrial membrane. In Ion Channels, Vol. 4.

T. Narahashi, editor. Plenum Press, New York. 169-202.

• C

ONNOR

JR., M

ENZIES

SL. (1995). Cellular management of iro in the brain. J. Neurol. Sci. 134: 33-44.

• C

ONNOR

JR., M

ENZIES

S

L

. (1996). Relationship of iron to oligodentrocytes and myelination. G

LIA

. 17: 83-93.

• C

ROFTS

AR. (2004). The cytochrome bc1 complex: function in the context of structure. Annu Rev. Physiol. 66: 689-733.

• D

E

G

RANDIS

D. and M

INARDI

C. (2002). Acetyl-L-Carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study. Drugs R. D. 3:

223-231.

• D

EVLIN

TM. (1997). Biochimica con aspetti clinici. III Edizione, Idelson-Gnocchi, Napoli.

• D

HITAVAT

S., O

RTIZ

D., S

HEA

TB., R

IVERA

ER. (2002). Acetyl-l- carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and atp levels. Neurochem. Res. 27: 501-505.

• D

IATCHENKO

L., L

AU

YF., C

AMPBELL

AP., C

HENCHIK

A., M

OQADAM

F., H

UANG

B., L

UKYANOV

S., L

UKYANOV

K., G

URSKAYA

N., S

VERDLOV

ED.

AND

S

IEBERT

PD. (1996). Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA. 93: 6025-6030.

• D

OLEZAL

V.

AND

T

UCEK

S. (1981). Utilization of citrate, acetylcarnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices. J. Neurochem. 36: 1323-1330 .

• E

DWARDS

YH., C

HASE

JF., E

DWARDS

MR.

AND

T

UBBS

PK. (1974).

Carnitine acetyltransferase: the question of multiple forms. Eur. J.

Biochem. 46: 209-215.

(4)

• E

ZAKI

J.

AND

K

OMINAMI

E. (2004). The intracellular location and function of proteins of neuronal ceroid lipofuscinoses. Brain Pathol.

14: 77-85.

• F

ALCHETTO

S., K

ATO

G., P

ROVINI

L. (1971). The action of carnitines on cortical neurons. Can. J. Physiol. Pharmacol. 49: 1-7.

• F

ISHER

RP., T

OPPER

JN., C

LAYTON

DA. (1987). Promoter selection in human mitochondria involves binding of a transcription factor to orientation-independent upstream regulatory elements. Cell. 50: 247- 258.

• F

OSSALE

E., W

OLF

P., E

SPINOLA

JA., L

UBICZ

-N

AWROCKA

T., T

EED

AM., G

AO

H., R

IGAMONTI

D., C

ATTANEO

E., M

AC

D

ONALD

ME., C

OTMAN

SL. (2004). Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis. BMC Neuroscience. 5: 57.

• G

^ADALETA

MN., C

ORMIO

A., P

ESCE

V., L

EZZA

AM.

AND

C

ANTATORE

P. (1998). Aging and mitochondria. Biochimie. 80: 863-870.

• G

ADALETA

MN., P

ETRUZZELLA

V., D

ABBABBO

I., O

LIVIERI

C., F

RACASSO

F., L

OGUERCIO

P

OLOSA

P., C

ANTATORE

P., (1994) Mitochondrial DNA transcription and translation in aged rat: effect of acetyl-L-carnitine. Ann. N.Y. Acad. Sci. 717: 150-160.

• G

^ADALETA

MN., P

ETRUZZELLA

V., F

RACASSO

F., F

ERNANDEZ

-S

ILVA

P., C

ANTATORE

P. (1990). Acetyl-L-Carnitine increases cytochrome oxidase subunit I mRNA content in Hypothyroid rat liver. FEBS Lett.

277: 191-193.

• G

^AMBI

D., O

NOFRJ

M., C

ALVANI

M., F

ARICELLI

A., D

EL

R

E

ML., B

AZZANO

S., C

UTARELLA

R., F

ULGENTE

T.

AND

C

OLANGELO

U. (1989).

Neurophysiological studies of L-acetylcarnitine administration in man.

Drugs Exp. Clin. Res. 15: 435-446.

• G

^ECELE

M., F

RANCESETTI

G.

AND

M

ELUZZI

A. (1991). Acetyl-L-

carnitine in aged subject with major depression: clinical efficacy and

effects on the circadian rhythm of cortisol. Dementia. 2: 333-337.

(5)

• G

ERBER

G., Y

OUN

DH., H

SU

CH., I

SEW

D., R

ANDIC

M. (2000). Spinal dorsal horn synaptic plasticity: involvement of group I metabotropic glutamate receptors. Prog. Brain. Res. 129: 115-134.

• G

IBSON

GE.

AND

S

HIMADA

M. (1980). Studies on the metabolic pathway of the acetyl group for acetylcholine synthesis. Biochem.

Pharm. 29: 167-174.

• G

INCEL

D., Z

AID

H., S

HOSHAN

-B

ARMATZ

V. (2001). Calcium binding and translocation by the voltage-dependent anion channel: a possible regulatory mechanism in mitochondrial function. Biochem. J. 358:147- 155.

• G

URSKAYA

NG., D

IATCHENKO

L., C

HENCHIK

A., S

IEBERT

PD., K

HASPEKOV

GL., L

UKYANOV

KA., V

AGNER

LL., E

RMOLAEVA

OD., L

UKYANOV

SA.

AND

S

VERDLOV

ED. (1996). Equalizing cDNA subtraction based on selective suppression of polymerase chain reaction: cloning of Jurkat cell transcripts induced by phytohemaglutinin and phorbol 12-myristate 13-acetate. Anal.

Biochem. 240: 90-97.

• H

ALLIWELL

B., G

UTTERIDGE

JM. (1989). Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. Free radicals in biology and medicine. New York, NY: Oxford University Press. 86-179.

• H

ARMAN

D. (1972). The biological clock: the mitochondria?. J. Am.

Geriat. Soc. 20: 145-147.

• H

ARMAN

D. (1981). The aging process..Proc. Natl. Acad. Sci. USA. 78:

7124-7128.

• H

INERFELD

D., T

RAINI

MD., W

EINBERGER

RP., C

OCHRAN

B., D

OCTROW

SR., H

ARRY

J., M

ELOV

S. (2004). Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J. Neurochem. 88: 657-667.

• H

^OSTETLER

KY. (1991). Effect of thyroxine on the activity of mitochondrial cardiolipin synthase in rat liver. Biochim. Biophys. Acta.

1086: 139-140.

(6)

• I

MPERATO

A., R

AMACCI

MT.

AND

A

NGELUCCI

L. (1989). Acetyl-L- carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats. Neurosi. Lett. 107: 251-255.

• I

NDIVERI

C., T

ONAZZI

A.

AND

P

ALMIERI

F. (1994). The reconstituted carnitine carrier from rat liver mitochondria: evidence for a transport mechanism different from that of the other mitochondrial translocators.

Biochim. Biophys. Acta. 1189: 65-73.

• I

^WAI

K, D

RAKE

SK., W

EHR

NB. (1998). Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2:

implications for degradation of oxidized proteins. Proc. Nat. Acad. Sci.

USA. 95: 4924-4928.

• J

ANSEN

JK.

AND

N

ICHOLLS

JG. (1973). Conductance changes, an electrogenic pump and the hyperpolarization of leech neurones following impulses. J. Physiol. 229: 635-655 .

• K

AKHLON

O, G

RUENBAUM

Y, C

ABANTCHIK

ZL. (2001). Repression of the heavy ferrtin chain increases the labile iron pool of human k562 cells. B

IOCHEM

.

J

. 356: 311-316.

• K

^ATZ

ML. (1996). Decreased plasma carnitine and trimethyl-l-lysine levels associated with lysosomal accumulation of a trimethyl-l-lysine containing protein in Batten disease. Biochim. Biophys. Acta. 1317:

192-198.

• K

^ATZ

ML., R

ICE

LM., G

AO

CL. (1997). Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid-lipofuscinosis. J. Neurosci. Res. 50: 123-132.

• K

^AUR

J., S

HARMA

D.

AND

S

INGH

R. (2001). Acetyl-L-carnitine enhances Na(+), K(+)-ATPase glutathione-S-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci. Lett. 301: 1-4.

• K

^ENTROTI

S., R

AMACCI

MT.

AND

V

ERNADAKIS

A. (1992). Acetyl-L-

carnitine has a neuromodulatory influence on neuronal phenotypes

during early embryogenesis in the chick embryo. Brain Res. Dev. Brain

Res. 70: 259-266.

(7)

• K

IDO

Y., T

AMAI

I., O

HNARI

A., S

AI

Y., K

AGAMI

T., N

EZU

J., N

IKAIDO

H., H

ASHIMOTO

N., A

SANO

M.

AND

T

SUJI

A. (2001). Functional relevance of carnitine transporter OCTN2 to brain distribution of L- carnitine and acetyl-L-carnitine across the blood-brain barrier. J.

Neurochem. 79: 959-969.

• K

^OEPSELL

H. (1998). Organic cation transporters in intestine, kidney, liver, and brain. Annu. Rev. Physiol. 60: 243-266.

• K

^OTAKE

Y.

AND

O

HTA

S. (2003). MPP

⁺

analogs acting on mitochondrial and inducing neuro-degeneration. Curr. Med. Chem. 10: 2507-2516.

• K

URATSUNE

H., Y

AMAGUTI

K., T

AKAHASHI

M., M

ISAKI

H., T

AGAWA

S.

AND

K

ITANI

T. (1994). Acylcarnitine deficiency in chronic fatigue syndrome. Clin. Infect. Dis. Suppl 1: S62-7.

• L

EVENSON

CW., F

ITCH

CA. (2000). Effect of altered thyroid hormone status on rat brain ferritin H and ferritin L mRNA during postnatal development. Brain Res. Dev. Brain Res. 119: 105-109.

• L

EVINE

J., K

APLAN

Z., P

ETTEGREW

JW., M

C

LURE

RJ., G

ERSHON

S., B

URIAKOVSKY

I., C

OHEN

H. (2004). Effect of intraperitoneal acetyl-L- Carnitine (ALCAR) on anxiety-like. Int. J. Neuropsychophar. 20: 1-10.

• L

EVY

M., F

AAS

GC., S

AGGAU

P., C

RAIGEN

WJ., S

WEATT

JD. (2003).

Mitochordrial regulation of synaptic plasticity in the hippocampus. J.

Biol. Chem. 278: 17727-17734.

• L

INNANE

AW., M

ARZUKI

S., O

ZAWA

T., T

ANAKA

M. (1989).

Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet i. 642-645.

• L

OMBARDO

P., S

CURI

R., C

ATALDO

E., C

ALVANI

M., N

ICOLAI

R., M

OSCONI

L., B

RUNELLI

M. (2004). Acetyl-L-carnitine induces a sustained potentiation of the afterhyperpolarization. Neuroscience. 128:

293-303.

• M

^ALOW

BA., B

AKE

AC., G

LEASON

PM

AND

B

LASS

JP. (1987). Carnitine in Alzheimer’s disease fibroblast and patients. Clin. Res. 35: 579A.

• M

^ARTIGNONI

E., F

ACCHINETTI

F., S

ANCES

G., P

ETRAGLIA

F., N

APPI

G.

AND

G

ENAZZANI

AR. (1988). Acetyl-L-carnitine acutely administered

(8)

raises beta-endorphin and cortisol plasma levels in humans. Clin Neuropharmacol. 11: 472-477.

• M

ATHUPALA

SP., R

EMPEL

A., P

EDERSEN

PL. (1995). Glucose catabolismin cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J. Biol. Chem. 270: 16918-16925.

• M

AZZIO

E., Y

OON

KJ., S

OLIMAN

KF. (2003). Acetyl-L-Carnitine cytoprotection against 1-methyl-4-phenylpyridinium toxicity in neuroblastoma cells. Biochem. Pharm. 66: 297-306.

• M

OZZACHIODI

R., S

CURI

R., R

OBERTO

M.

AND

B

RUNELLI

M. (2001).

Caulerpenyne, a toxin from the seaweed Caulerpa taxifolia, depresses after hyperpolarization in invertebrate neurons. Neuroscience. 107:

519-526.

• N

AKASHIMA

RA., S

COTT

LJ., P

EDERSEN

PL. (1986). The role of mitochondrial hexokinase in the abnormal energy metabolism of tumor cell lines. Ann. N. Y. Acad. Sci. 488: 438-450.

• O

HASHI

R., T

AMAI

I., Y

ABUUCHI

H., N

EZU

J., O

KU

A., S

AI

Y., S

HIMANE

M.

AND

T

SUJI

A. (1999). Na

⁺

-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological revelance. J. Pharmacol. Exp. Ther. 291: 778-784.

• O

KADA

T., T

ANAKA

M., K

URATSUNE

H., W

ATANABE

Y., S

ADATO

N. (2004). Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol. 4: 14.

• O

^NOFRJ

M., G

HILARDI

MF., F

ARICELLI

A., B

ODIS

-W

OLLNER

I.

AND

C

ALVANI

M. (1987). Effect of levo-acetylcarnitine on P300-like potentials of the normal monkey. Drugs Exp. Clin. Res. 13: 407-415.

• O

^RINO

K., L

EHMAN

L., T

SUJI

Y., A

YAKI

H., T

ORTI

SV., T

ORTI

FM.

(2001). Ferritin and the response to oxidative stress. B

IOCHEM

. J. 357:

241-247.

• O

ZAWA

T. (1997). Genetic and functional changes in mitochondria associated with aging. Physiol. Rev. 77: 425-464.

• P

ANTOPOULOS

K., H

ENTZE

MW. (1998). Activation of iron regulatory protein-1 by oxidative stress in vitro. P

ROC

. N

ATL

. A

CAD

. S

CI

. USA. 14:

2917-2924.

(9)

• P

ARADIES

G., R

UGGIERO

FM., P

ETROSILLO

G., G

ADALETTA

MN., Q

UAGLIARELLO

E. (1994). Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett. 350: 213-215.

• P

EDERSEN

PL. (1978). Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res. 22: 190-274.

• P

^ETZOLD

A., E

IKELENBOOM

MJ., G

VERIC

D., K

EIR

G., C

HAPMAN

M., L

AZERON

RH., C

UZNER

ML., P

OLMAN

CH., U

ITDEHAAG

BM., T

HOMPSON

EJ., G

IOVANNONI

G. (2002). Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.

Brain. 125: 1462-1473.

• P

ISANO

C., C

AMERINI

B., C

ASTORINA

M., M

ORABITO

E., C

ARBONETTI

A., P

UCCI

A., C

ALVANI

M. (1996). Acetyl-L-Carnitine modulates histone H4 acetylation, effects on gene expression and differentiation.

24

^o

Meeting of the Federation of European Biochemical Society, FEBS, Barcelona 7-12 July, Abstr .155.

• P

RICKAERTS

J., B

LOKLAND

A., H

ONIG

W., M

ENG

F., J

OLLES

J. (1995).

Partial discrimination learning and choline acetyltransferase activity in streptozotocin-treated rats:effect of chronic treatment with Acetyl-L- Carnitine. Brain Res. 647: 142-146.

• Q

^I

Y., J

AMINDAR

TM., D

AWSON

G. (1995). Hypoxia alters iron Homeostasis and induces ferritin synthesis in oligodentrocytes. J.

N

EUROCHEM

. 64: 2458-2464.

• R

^AI

G., W

RIGHT

G., S

COTT

L., B

ESTON

B., R

EST

J.

AND

E

XTON

-S

MITH

AN. (1990). Double-blind, placebo controlled study of acetyl- L- carnitine in patients with Alzheimer’s dementia. Curr. Med. Res. Opin.

11: 638-647.

• R

^APIZZI

E., P

INTON

P., S

ZABADKAI

G., W

IECKOWSKI

MR., V

ANDECASTEELE

G., B

AIRD

G., T

UFT

RA., F

OGARTY

KE., R

IZZUTO

R. (2002). Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca

²⁺

microdomains to mithocondria. J.

Cell. Biol. 159: 613-624.

(10)

• R

AUSH

WD., H

IRADA

Y., N

AGATSU

T., R

IEDERER

P., J

ELLINGER

K. (1988). Tyrosine Hydroxylase activity in caudete nucleus from Parkinson’s disease: effect of iron and phosphorylating agents. J.

Neurochem. 50: 202-208.

• R

EBOUCHE

CJ., S

EIM

H. (1998). Carnitine metabolism and its regulation in microorganisms and mammals. Annu. Rev. Nutr. 18: 39-61.

• R

OGERS

J., M

UNRO

H. (1987). Translation of ferritin light and heavy subunit mRNAs is regulated by intracellular chetable iron levels in rat hepatoma cells. Proc. Natl. Acad. Sci. USA. 84: 2277-2281.

• R

OSKAMS

AJ., C

ONNOR

JR. (1994). Iron, transferrin, and ferritin in the rat brain during development and aging. J. Neurochem. 63: 709-716.

• R

OSTOVTSEVA

TK., K

OMAROV

A., B

EZRUKOV

SM., C

OLOMBINI

M. (2002). Dynamics of nucleotides in VDCA Channels: structure-specific noise generation. Biophys. J. 82: 193-205.

• S

ANYAL

B., P

OLAK

PE.,

SZUCHET

S. (1996). Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodentrocytes. J. Neurosci. Res. 46: 187-197.

• S

ÄVENSTRAND

H., B

ROSCHÉ

M., Ä

NGEHAGEN

M.

AND

S

TRID

Å., (2000).

Molecular marker for ozone stress isolated by Suppression Subtractive Hybridisation: specificity of gene expression and identification of a novel stress-regulated gene. Plant Cell Environ. 23: 689-700.

• S

^CARPULLA

RC. (1996). Nuclear respiratory factors and the pathways of nuclear mitochondrial interaction. Trends Cardiovasc. Med. 6: 39-45.

• S

^CHALINSKE

KL., E

ISENSTEIN

RS. (1996). Phosphorilation and activation of both iron regulatory protein 1 and 2 in HL-60 cells. J Biol.

Chem. 271: 7168-7176.

• S

^CURI

R., M

OZZACHIODI

R., B

RUNELLI

M. (2002). Activity-dependent increase of the AHP amplitude in T sensory neurons of the leech. J.

Neurophysiol. 88: 2490-2500.

• S

HINOHARA

Y., I

SHIDA

T., H

INO

M., Y

AMAZAKI

N., B

ABA

Y., T

ERADA

H. (2000). Characterization of porin isoforms expressed in tumor cells.

Eur. J. Biochem. 267: 6067-6073.

(11)

• S

HINOHARA

Y., S

AGAWA

I.,

ICHIHARA

J., Y

AMAMOTO

K., T

ERAO

K., T

ERADA

H. (1997). Source of ATP for hexokinase-catalyzed glucose phosphorylation in tumor cells: dependence on the rate of oxidative phosphorylation relative to that of extramitochondrial ATP generation.

Biochim. Biophys. Acta. 1319: 319-330.

• S

^HUG

AL., S

CHMIDT

MJ., G

OLDEN

G.T., F

ARIELLO

R.G. (1982). The distribution and role of carnitine in the mammalian brain. Life Sci. 31:

2869- 2874.

• S

OFIC

E., R

IEDERER

P., H

EINSEN

H.,

ET AL

. (1988). Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural. Transm. 74: 199-205.

• S

OHAL

RS.

AND

B

RUNK

UT. (1996). Lipofuscin as an indicator of oxidative stress and aging. Adv. Exp. Med. Biol. 266: 17-26.

• S

ONG

J., M

IDSON

C., B

LACHLY

-D

YSON

E., F

ORTE

M., C

OLOMBINI

M. (1998). The topology of VDCA as probed by biotin modification. J.

Biol. Chem. 273: 24406-24413.

• S

ONNEWALD

U., W

ESTERGAARD

N., H

ASSEL

B., M

ULLER

TB., U

NSGARD

G., F

ONNUM

F., H

ERTZ

L., S

CHOUSBOE

A.

AND

P

ETERSEN

SB. (1993).

NMR spectroscopic studies of 13C acetate and 13C glucose metabolism in neocortical astrocytes: evidence for mitochondrial heterogeneity. Dev. Neurosci. 15: 351-358.

• S

^TEFFEN

V., S

ANTIAGO

M.,

DE LA

C

RUZ

CP., R

EVILLA

E., M

ACHADO

A., C

ANO

J.(1995). Effect of intraventricular injection of 1-methyl-4- phenilpyridinium: protection by Acetyl-L-Carnitine. Hum. Exp.

Toxicol. 14: 865-871.

• S

^TEIBER

A., K

ERNER

J., H

OPPEL

CL. (2004). Carnitine: a nutritional, biosynthetic, and functional perspective. Mol. Aspects Med. 25: 455- 473.

• T

ACCHINI

L., R

ECALCATI

S., B

ERNELLI

-Z

AZZERA

A., C

AIRO

G. (1997).

Induction of ferritin synthesis in ischemic-reperfused rat liver: analysis of the molecular mechanisms. Gastroenterology. 113: 946-953.

• T

^AMAI

I.

AND

T

SUJI

A. (2000). Transporter-mediated permeation of

drugs across the blood-brain barrier. J. Pharm. Sci. 89: 1371-1388.

(12)

• T

AMAI

I., O

HASHI

R., N

EZU

J., Y

ABUUCHI

H., O

KU

A., S

HIMANE

M., S

AI

Y.

AND

T

SUJI

A. (1998). Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273: 20378-20382.

• T

^ANG

Y., Z

UCHER

RS. (1997). Mitochondrial involvement in post- tetanic potentiation of synaptic trans mission. Neuron 18: 483-491.

• T

^ORTI

FM., T

ORTI

SV. (2002). Regulation of ferritin genes and protein.

Blood. 99, 10.

• T

RAINA

G., V

ALLEGGI

S., B

ERNARDI

R., R

IZZO

M., C

ALVANI

M., N

ICOLAI

R., M

OSCONI

L., D

URANTE

M., B

RUNELLI

M. (2004).

Identification of differentially expressed genes induced in the rat brain by acetyl-L-carnitine as evidenced by suppression subtractive hybridisation. Molec. Brain Res. 132: 57-63.

• T

^SUJI

Y., A

YAHI

H., W

HITMAN

SP., M

ORROW

CS., T

ORTI

SV., T

ORTI

FM. (2000). Coordinate transcriptional and translation regulation of ferritin in response to oxidative stress. M

OL

. C

ELL

B

IOL

. 20: 5818-5827.

• T

SUJIMOTO

Y., S

HIMIZU

S. (2001). The voltage-dependent anion channel: an essential player in apoptosis. Biochimie. 84: 187-193.

• V

AN

E

SSEN

DC. (1973). The contribution of membrane hyperpolarization to adaptation and conduction block in sensory neurones of the leech. J. Physiol. 230: 509-534.

• V

^ANDER

H

EIDEN

MG., C

HANDEL

NS., L

I

XX., S

CHUMACKER

PT., C

OLOMBINI

M., T

HOMPSON

CB. (2000). Outer mithocondrial membranr permeability can regulate coupled respiration and cell survival. Proc.

Natl. Acad. Sci. USA. 97: 4666-4671.

• V

ANDER

H

EIDEN

MG., L

I

XX., G

OTTLEIB

E., H

ILL

RB., T

HOMPSON

CB.,

COLOMBINI

M. (2001). Bcl-xL promoters the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. J. Biol. Chem. 276: 19414-19419.

• V

IRMANI

A., G

AETANI

F., B

INIENDA

Z., X

U

A., D

UHART

H., A

LI

SF.(2004). Role of mitochondrial dysfunction in neurotoxicity of

(13)

MPP

⁺

: partial protection of PC12 cells by Acetyl-L-Carnitine. Ann.

N.Y. Acad. Sci. 1025: 267-73.

• V

IRMANI

MA.

AND

B

INIENDA

Z. (2004). Role of carnitine esters in brain neuropathology. Mol. Aspect Med. 25: 533-549.

• V

IRMANI

MA., B

ISELLI

R., S

PADONI

A., R

OSSI

S., C

ORICO

N., C

ALVANI

M., F

ATTOROSSI

A., D

E

S

IMONE

C., A

RRIGO

-M

ARTELLI

E. (1995).

Protective actions of L-Carnitine and Acetyl-L-Carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors.

Pharmacol. Res. 32: 383-389.

• V

IRMANI

MA., C

ASO V

., S

PADONI

A., R

OSSI

S., R

USSO

F., G

AETANI

F. (2001). The action of Acetyl-L-Carnitine on the neurotoxicity evoked by amyloid fragments and peroxide on primary rat cortical neurones.

Ann. N. Y. Acad. Sci. 939: 162-178.

• W

EEBER

EJ., L

EVY

M., S

AMPSON

MJ., A

NFLOUS

K., A

RMSTRONG

DL., B

ROWN

SE., S

WEATT

JD., C

RAIGEN

WJ. (2002). The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. J. Biol. Chem. 277: 18891-18897.

• W

EI

YH. (1998). Oxidative stress and mitochondrial DNA mutations in Human aging. Proc. Soc. Exp. Biol. Med. 217: 53-63.

• W

^HITE

HL.

AND

S

CATES

PW. (1990). Acetyl-L-carnitine as a precursor of acetylcholine. Neurochem. Res. 15: 597-601.

• W

^ORWOOD

M. (1980). Serum ferritin and iron deficiency anaemia in hospital patients. Lancet. 1: 375-376.

• W

^U

CG., G

ROENINK

M., B

OSMA

A., R

EITSMA

PH.,

VAN

D

EVENTER

SJH., C

HAMULEAU

RAFM. (1997). Rat ferritin-H: cDNA cloning,differential expression and localization during hepatocarcinogenesis.

Carcinogenesis. 18: 47-52.

• W

U

X., P

RASAD

PD., L

EIBACH

FH.

AND

G

ANAPATHY

V. (1998). cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporters family.

Biochem. Biophys. Res. Comm. 246: 589-595.

(14)

• X

U

X., D

ECKER

W., S

AMPSON

MJ., C

RAIGEN

WJ., C

OLOMBINI

M. (1999). Mouse VDAC isoforms expressed in yeast: channel properties and their roles in mitochondrial outer membrane permeability. J.

Membr. Biol. 170: 89-102.

• Y

ASUI

F., M

ATSUGO

S., I

SHIBASHI

M., K

AJITA

T., E

ZASHI

Y., O

OMURA

Y., K

OJO

S., S

ASAKI

K. (2002). Effects of chronic Acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice. Neurosci Lett. 334: 177-180.

• Y

^OUNG

MJ., B

OULTON

AJ., M

AC

L

EOD

AF., W

ILLIAMS

DR.

AND

S

ONKSEN

PH. (1993). A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 36: 150-154.

• Z

^ACCARDI

ML., R

ISTORI

C., B

ERTUCCI

., M

ONTANO

A., M

ACCHI

M., B

RUNELLI

M. (2004). Effetti della Acetil-L-Carnitina, (ALC) su forme di apprendimento non associativo nella sanguisuga Hirudo medicinalis.

Proc. XXI Congr. Naz. Soc. Ital. Ecologia, Padova, Italy, 15-17 September, 2004.

• Z

ACCARDI

ML., T

RAINA

G., C

ATALDO

E., B

RUNELLI

M. (2001).

Nonassociative learning in the leech Hirudo medicinalis. Behav. Brain Res. 126: 81-92.

• Z

ACCARDI

ML., T

RAINA

G., C

ATALDO

E., B

RUNELLI

M. (2004).

Sensitization and dishabituation of swin induction in the leech Hirudo medicinalis: role of serotonin and cyclic AMP. Behav. Brain Res. 153:

317-326.

• Z

^AHRINGER

J., B

ALIGA

BS., M

UNRO

HN. (1976). Novel mechanism for translational control in regulation of ferritin synthesis by iron. Proc.

Natl. Acad. Sci. USA. 73: 857-861.